ENLV is currently covered by 2 analysts
Enlivex Therapeutics Ltd's activity chart (see below) currently has 19 price targets and 40 ratings on display. The stock rating distribution of ENLV is 100% BUY.
Analysts' price targets on this stock were met 4.55% of the time, taking 91.5 days on average.
Highest price target for ENLV is $245, Lowest price target is $35.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 03-Aug-2026. First documented stock forecast 17-Feb-2015.
Currently out of the existing stock ratings of ENLV, 4 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Jan-2016
3 months 19 days ago
(03-Aug-2026)
2/11 (18.18%)
$1449.59 (629.16%)
366
Buy Since 26-Sep-2024
11 months 29 days ago
(24-Nov-2025)
0/1 (0%)
$2740.78 (722.78%)
Buy Since 17-Feb-2015
$28799.77
$172798.62
10 years 2 months 28 days ago
(25-Aug-2016)
0/2 (0%)
$11711.77 (68.54%)
Buy Since 16-Nov-2015
$301176.47
$301176.47
11 years 3 days ago
(19-Nov-2015)
0/2 (0%)
$260376.47 (638.18%)
What is ENLV (Enlivex Therapeutics Ltd) average time for price targets to be met?
Which analyst most recently updated their price target on ENLV (Enlivex Therapeutics Ltd)?
Which analyst has the lowest performance score on ENLV (Enlivex Therapeutics Ltd) with a proven track record?
Which analyst has the most public recommendations on ENLV (Enlivex Therapeutics Ltd)?
Which analyst is the currently most bullish on ENLV (Enlivex Therapeutics Ltd)?
Which analyst is the currently most reserved on ENLV (Enlivex Therapeutics Ltd)?